Key facts
- It has raised $3.4M.
- Notable investors include Google for Startups, Wayra, Eoniq Fund, Caelestinus, Axon Partners Group — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Sincrolab
- ·The full record, as it builds
Funding rounds
No funding rounds for Sincrolab are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sincrolab
Developer of a training platform designed to help in the recovery and development of cognitive abilities. The company's platform offers personalized, standardized, and scientifically validated cognitive stimulation training focused on the educational and health field, enabling health professionals to manage and generate personalized cognitive training plans and patients to get rehabilitation for neurodevelopmental problems.
- Sector
- Healthcare
- HQ
- Madrid, Spain
- Founded
- 2013
- Employees
- 22
- Website
- sincrolab.es/
- Ownership
- Privately Held (backing)
Sincrolab doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sincrolab shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sincrolab in its N-PORT filings yet. We sweep new filings monthly.